Current stock page

Financial Data

ARGX Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

ARGXargenx SE

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 9/10
$960.04−$21.29 (−2.17%)

Latest quote

  • Momentum
    74
  • Value
    70
  • Quality
    77
  • Risk resilience
    70
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302025-12-312025-06-302024-12-312024-09-302024-06-302024-03-31
Revenue$1.72B$2.82B$3.21B$947.96M$573.24M$573.24M$401M$401M
Gross Profit$1.56B$2.54B$2.87B$837.21M$514.16M$514.16M$357.82M$357.82M
Operating Income$485M$846.83M$850.77M$203.84M$14.19M$14.19M-$93.42M-$93.42M
Net Income$506M$838.82M$1.05B$245.36M$91.41M$91.41M-$61.6M-$61.6M
EPS$8.07$13.49$14.25$6.85$1.52$1.52-$1.04-$1.04
Cash flow statement
8 periods
Metric2026-06-302025-12-312025-06-302024-12-312024-06-302023-12-312023-06-302022-12-31
Operating Cash Flow$751.74M$407.8M$437.85M$41.91M-$124.66M-$134.89M-$258.5M-$343.95M
Capital Expenditure-$3M-$900.21K-$5.25M-$990K-$811K-$333K-$479.78K-$611K
Free Cash Flow$748.74M$406.9M$432.61M$40.92M-$125.47M-$135.22M-$258.98M-$344.56M
Net Cash Provided By Operating Activities$751.74M$407.8M$437.85M$41.91M-$124.66M-$134.89M-$258.5M-$360.62M
Balance sheet
8 periods
Metric2026-06-302025-12-312025-06-302024-12-312024-06-302023-12-312023-06-302022-12-31
Total Assets$10.03B$8.68B$7.18B$6.2B$4.8B$4.54B$3.19B$3.13B
Total Debt$47M$83.49M$43.15M$39.05M$33.96M$20M$11.24M$12.43M
Cash And Cash Equivalents$3.58B$3.49B$2.09B$1.5B$1.44B$2.05B$1.11B$800.74M
Total Liabilities$1.62B$1.36B$1.08B$704.24M$534.31M$444.95M$335.74M$320.56M
Total Stockholders Equity$8.42B$7.32B$6.1B$5.5B$4.26B$4.1B$2.86B$2.81B
Key financial metrics
5 periods
Metric2026-06-302025-12-312025-06-302024-12-312024-06-30
P/E ratio31.5839.53———
P/B ratio7.086.97———
P/S ratio—————
Debt To Equity0.010.010.010.010.01
Free Cash Flow Yield1.94%1.64%———
Financial ratios
5 periods
Metric2026-06-302025-12-312025-06-302024-12-312024-06-30
P/E ratio31.5839.53———
P/B ratio7.086.97———
P/S ratio—————
Return On Equity22.40%17.64%—1.08%-6.30%
Debt To Equity0.010.010.010.010.01

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe45.54x
Pb7.22x
Revenue Growth Yoy200.23%
EPS Growth Yoy430.92%
Gross Margin90.49%
Operating Margin29.35%
ROE16.86%
ROIC13.96%
Debt To Equity0.01
FCF Yield1.84%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$960.04
Volume225,894
RSI (14)58.77
MACD18.56
MACD signal6.81
MACD histogram11.75
ADX (14)21.04
SMA (50)$923.88
SMA (200)$860.28
ATR (14)$28.49
Historical volatility (annualized)36.68%
Volume (20-day average)412,042

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score70/100
Beta0.53
Annual volatility37.87%
Max Drawdown-28.58%
Sharpe Ratio0.28
VaR (95%, 1-day)-3.14%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

ARGX Financial Data FAQ

What is argenx SE's revenue?

argenx SE's revenue is one of the core financial data points for ARGX. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is argenx SE's revenue growing?

Revenue growth shows whether argenx SE is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is ARGX's EPS?

ARGX's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is argenx SE's net income?

argenx SE's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does argenx SE generate?

Free cash flow shows how much cash argenx SE generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does argenx SE have?

Cash and debt help frame ARGX's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.